Breaking

US stocks close mixed as Dow drops 289 points despite tech resilience
Nikkei 225 Index dips as Brent crude oil price jumps to $100
Here’s how long an oil shock-driven bear market lasts on average
Anthropic in talks with Blackstone, PE firms for AI venture: report
Morning brief: Asian markets fall, US launches new trade probe
Bitcoin Hyper Price Prediction: Pepeto Outperforms HYPER With 267x Target as MiCA Opens 30 Countries
Bitcoin Facing $75K Sell Wall Despite Whale and Institution Buy-Ins, Here’s Why
Ripple Stock Buyback Raises Valuation to $50B, XRP Reacts Mildly

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Top

Type above and press Enter to search. Press Esc to cancel.